IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1276-1285 out of 1285.

<< < 47 | 48 | 49 | 50 | 51 | 52

Public Release: 18-Aug-2015
American Chemical Society 250th National Meeting & Exposition
Powdered cranberry combats colon cancer in mice
Cranberries are often touted as a way to protect against urinary tract infections, but that may be just the beginning. Cranberry extracts reduced the size and number of colon tumors in mice, say researchers. Identifying the therapeutic molecules in the fruit could lead to a better understanding of its anti-cancer potential, they say. The team will describe their approach at the 250th National Meeting & Exposition of the American Chemical Society.

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society

Public Release: 17-Aug-2015
Journal of Clinical Oncology
Drinking coffee daily may improve survival in colon cancer patients
Regular consumption of caffeinated coffee may help prevent the return of colon cancer after treatment and improve the chances of a cure, according to a new, large study from Dana-Farber Cancer Institute that reported this striking association for the first time.
National Institutes of Health, Alliance for Clinical Trials in OncologyPharmacia, Upjohn Companythe National Cancer Institute

Contact: Anne Doerr
anne_doerr@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute

Public Release: 17-Aug-2015
Journal of Clinical Oncology
Genetic test could improve blood cancer treatment
Testing for genetic risk factors could improve treatment for myeloma -- a cancer of the blood and bone marrow -- by helping doctors identify patients at risk of developing more aggressive disease. New research, published in the Journal of Clinical Oncology today (Monday), found as few as nine genetic features would need to be tested to identify high-risk patients who might benefit from intensive treatment.
Myeloma UK, Cancer Research UK, NIHR Biomedical Research Centre at The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research

Contact: Claire Hastings
chastings@icr.ac.uk
020-715-35380
Institute of Cancer Research

Public Release: 17-Aug-2015
Journal of Clinical Oncology
Aspirin reverses obesity cancer risk
Research has shown that a regular dose of aspirin reduces the long-term risk of cancer in those who are overweight in an international study of people with a family history of the disease.
Medical Research Council, Cancer Research UK, European Union, Bayer Pharma

Contact: Helen Rae
helen.rae@ncl.ac.uk
44-019-120-87374
University of Leeds

Public Release: 17-Aug-2015
Nature Cell Biology
MD Anderson study reveals new insight into tumor progression
Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.

Contact: Ron Gilmore
rlgilmore1@mdanderson.org
713-745-1898
University of Texas M. D. Anderson Cancer Center

Public Release: 17-Aug-2015
Journal of Clinical Oncology
First-of-its-kind study finds music therapy lowers anxiety during surgical breast biopsies
A first-of-its-kind study published in the Journal of Clinical Oncology finds that music therapy lessened anxiety for women undergoing surgical breast biopsies for cancer diagnosis and treatment. The two-year study out of University Hospitals Seidman Cancer Center involved 207 patients.
Kulas Foundation

Contact: George Stamatis
george.stamatis@uhhospitals.org
216-844-2555
University Hospitals Case Medical Center

Public Release: 17-Aug-2015
Proceedings of the National Academy of Sciences
'Jumping genes' unusually active in many gastrointestinal cancers, studies find
Results of a trio of studies done on human cancer tissue biopsies have added to growing evidence that a so-called jumping gene called LINE-1 is active during the development of many gastrointestinal cancers. The results suggest that these elements, formally known as transposons, might one day serve as a marker for early cancer diagnosis.
Sol Goldman Pancreatic Cancer Research Center, Fred and Janet Sanfilippo Fund in the Department of Pathology at the Johns Hopkins University School of Medicine, Burroughs Wellcome Fund Career Award for Biomedical Scientists Program

Contact: Catherine Gara
ckolf@jhmi.edu
443-287-2251
Johns Hopkins Medicine

Public Release: 17-Aug-2015
Neurology
Study reveals effects of chemoradiation in brains of glioblastoma patients
A study from Massachusetts General Hospital Cancer Center researchers -- the first to examine the effects of combined radiation and chemotherapy on the healthy brain tissue of glioblastoma patients -- reveals not only specific structural changes within patients' brains but also that the effect of cancer therapy on the normal brain appears to be progressive and continues even after radiation therapy has ceased.
NIH/National Cancer Institute, American Cancer Society

Contact: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital

Public Release: 17-Aug-2015
Tobacco Control
Smoking cessation drug not boosting number of smokers who quit
The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine.
NIH/National Cancer Institute under the State and Community Tobacco Control Initiative

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 17-Aug-2015
Journal of Clinical Oncology
Drinking coffee daily may improve survival in colon cancer patients
Regular consumption of caffeinated coffee may help prevent the return of colon cancer after treatment and improve the chances of a cure, according to a new, large study from Dana-Farber Cancer Institute that reported this striking association for the first time.
NIH/National Cancer Institute, Pharmacia & Upjohn Company, Pfizer Oncology, National Institutes of Health

Contact: Anne Doerr
anne_doerr@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute

Showing releases 1276-1285 out of 1285.

<< < 47 | 48 | 49 | 50 | 51 | 52

  Search News Releases

     

Featured Multimedia

 

EurekAlert!